Robinson Smith Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $205K | Sell |
390
-358
| -48% | -$188K | 0.16% | 88 |
|
|
2025
Q1 | $474K | Buy |
748
+212
| +40% | +$134K | 0.4% | 50 |
|
|
2024
Q4 | $382K | Sell |
536
-44
| -8% | -$31.3K | 0.32% | 54 |
|
|
2024
Q3 | $610K | Sell |
580
-222
| -28% | -$233K | 0.52% | 44 |
|
|
2024
Q2 | $843K | Hold |
802
| – | – | 0.74% | 34 |
|
|
2024
Q1 | $772K | Buy |
802
+1
| +0.1% | +$962 | 0.74% | 38 |
|
|
2023
Q4 | $704K | Buy |
+801
| New | +$704K | 0.69% | 37 |
|